Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Liquid biopsy in lymphoma: Molecular methods and clinical applications.

Cancer treatment reviews - 1 Dec 2020

Cirillo Melita, Craig Alexander F M, Borchmann Sven, Kurtz David M

Abstract excerpt

In this article, we broadly review the application of cfDNA analysis to the diagnosis and management of lymphoma. We introduce the advantages of cfDNA measurement over conventional tissue biopsy and describe how cfDNA may be utilized for both genotyping and detection of minimal residual disease. First, we discuss genotyping, beginning with differences in identifying mutations from the blood plasma vs. from...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Circulating Tumor DNA
Share to Liquid Biopsy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Lymphoma

Share to Mutation

Share to Neoplasm, Residual

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 33049623
DOI: 10.1016/j.ctrv.2020.102106
PMCID: PMC8043056

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Liquid biopsy in lymphoma: Molecular methods and clinical applications.PMID 33049623Read ↗

Clinical applications of cell-free DNA-based liquid biopsy analysisSemantic proximity Read ↗

Circulating Tumor DNA in Lymphoma: Principles and Future DirectionsSemantic proximity Read ↗

Circulating tumor DNA in B-cell lymphoma: technical advances, clinical applications, and perspectives for translational researchSemantic proximity Read ↗

Circulating tumor DNA as a powerful tool in diagnostics and treatment outcome prediction - focus on large B-cell lymphomas and follicular lymphomas.Semantic proximity Read ↗

The clinical applications of next-generation sequencing and ctDNA/cfDNA in lymphoma.Semantic proximity Read ↗

Clinical use of circulating tumor DNA analysis in patients with lymphomaSemantic proximity Read ↗

The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomasSemantic proximity Read ↗

Circulating Tumor DNA in Lymphoma.Semantic proximity Read ↗

Liquid biopsy: current technology and clinical applicationsSemantic proximity Read ↗

Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.Semantic proximity Read ↗

Cell-free DNA and the monitoring of lymphoma treatment.Semantic proximity Read ↗

Liquid biopsies across the cancer care continuum.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.